Are you Dr. Weinstein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 42 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1830 E Monument St
Room 457
Baltimore, MD 21287Phone+1 410-502-2326Fax+1 410-955-7889- Is this information wrong?
Summary
- Dr. Edward Weinstein, MD is an infectious disease specialist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and Pennsylvania.
Education & Training
- Johns Hopkins UniversityFellowship, Infectious Disease, 2009 - 2012
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2006 - 2009
- Perelman School of Medicine at the University of PennsylvaniaClass of 2006
Certifications & Licensure
- MD State Medical License 2012 - 2025
- PA State Medical License 2006 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 10 citationsFDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development.James M Byrne, Ursula Waack, Edward A. Weinstein, Abhay Joshi, Simone M Shurland, Dmitri Iarikov, Jürgen B. Bulitta, Binh An Diep, Tina Guina, William W. Hope, Matthew...> ;Antimicrobial Agents and Chemotherapy. 2020 Dec 16
- 28 citationsUS Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®).Shabnam Naseer, Edward A. Weinstein, Daniel B. Rubin, Kalavati Suvarna, Xiaohui Wei, Karen Higgins, Avery Goodwin, Seong H. Jang, Dmitri Iarikov, John Farley, Sumathi ...> ;Clinical Infectious Diseases. 2021 Jun 15
- 9 citationsAssessing Animal Models of Bacterial Pneumonia Used in Investigational New Drug Applications for the Treatment of Bacterial Pneumonia.Ursula Waack, Edward A. Weinstein, John Farley> ;Antimicrobial Agents and Chemotherapy. 2020 Apr 21
- Join now to see all
Press Mentions
- Bruker Acquires Biomarker Imaging Technology Developer CanopySeptember 14th, 2020
- Special Report on Cancer: An Ever-Evolving PictureJune 6th, 2016
- Real-Time Tracking System Developed to Monitor Dangerous Bacteria Inside BodyOctober 22nd, 2014